[vc_row][vc_column][vc_column_text][/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
Registration Opens September 15
[/vc_column_text][/vc_column][/vc_row]
Recent Comments
No comments to show.
- by International Cardio-Oncology SocietyRichard Cheng MD, MSc. is cardiology faculty at the University of Washington, Seattle, with a focus in cardiomyopathies, cardio-oncology and cardiac imaging. He is Program Director for the HF fellowship and the Director of the Cardio-oncology Program. He has formal training with a Masters-in-Science in clinical trial design and biostatistics. He has extensive editorial experience, […]
- by International Cardio-Oncology SocietyDr Saro Armenian is a Pediatric Hematologist-Oncologist at City of Hope's (COH) main campus Duarte, US. He co-leads the COH Cancer Control and Population Sciences Program and directs the Center for Survivorship and Outcomes in the Hematologic Malignancies Research Institute. https://www.radcliffecardiology.com/video-index/cardiovascular-considerations-patients-undergoing-stem-cell-transplantation
- by International Cardio-Oncology SocietyDr Michelle Kittleson is Professor of Medicine at Cedars-Sinai and Director of Education in Heart Failure and Transplantation at the Smidt Heart Institute. She graduated from Harvard College and received her medical degree from Yale University. She completed residency training at Brigham and Women's Hospital and cardiology fellowship at Johns Hopkins, where she also received […]
- by International Cardio-Oncology SocietyDr. Paul Cottu, oncologist at Institut Curie, Paris, FR provides an overview of breast cancer therapies with associated cardiovascular toxicities. The original webinar can be viewed at the link below: https://www.radcliffecardiology.com/webinars/cardiotoxicity-breast-cancer-challenges-multimodal-therapies
- by International Cardio-Oncology SocietyDr Anne Blaes is a Professor in the Division of Hematology and Oncology at the University of Minnesota. She is the Director of the Screening, Prevention, Etiology, and Cancer Survivorship (SPECS) Program within the Masonic Cancer Center. View the original webinar here: https://www.radcliffecardiology.com/webinars/applying-esc-ic-os-guidelines-how-do-we-actually-do-risk-stratification
